Uniphar (LON:UPR) Hits New 12-Month Low – Should You Sell?

Uniphar plc (LON:UPR) shares reached a new 52-week low on Wednesday . The company traded as low as GBX 178 ($2.29) and last traded at GBX 180 ($2.32), with a volume of 14023 shares trading hands. The stock had previously closed at GBX 183.50 ($2.36).

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 310 ($3.99) target price on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Stock Down 1.9 %

The firm’s fifty day simple moving average is GBX 209.45 and its two-hundred day simple moving average is GBX 214.88. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43. The company has a market capitalization of £491.44 million, a price-to-earnings ratio of 1,321.43 and a beta of 0.75.

Uniphar Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, October 4th. Stockholders of record on Thursday, September 12th were given a €0.01 ($0.01) dividend. This represents a dividend yield of 0.25%. The ex-dividend date was Thursday, September 12th. Uniphar’s dividend payout ratio is currently 1,428.57%.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.